VALENCIA, Calif.–(BUSINESS WIRE)–Feb 3, 2026–
SetPoint Medical today announced the first patients in Chicago have been treated with the SetPoint System, an FDA-approved neuroimmune modulation therapy for adults living with moderately-to-severely active rheumatoid arthritis (RA). RA is a chronic autoimmune disease that can cause pain, swelling, stiffness, fatigue, and progressive joint damage. The procedure was performed by Webster Crowley, M.D., Professor, Department of Neurosurgery and Radiology at Rush University Medical Center.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260203600404/en/…